Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix

Stopped early · Phase 2

Conditions studied: Cervical Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine and cisplatin in treating patients who have refractory or recurrent cancer of the cervix.

Key facts

Study ID

NCT00006482

Run by

Gynecologic Oncology Group

Starts

2000-10-01

Last updated by the study team

2013-04-11

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama, United States
• Rational Therapeutics Inc. — Long Beach, California, United States
• Community Hospital of Los Gatos — Los Gatos, California, United States
• Chao Family Comprehensive Cancer Center — Orange, California, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• University of Illinois College of Medicine at Peoria — Peoria, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States
• Tufts University School of Medicine — Boston, Massachusetts, United States
• University of Mississippi Medical Center — Jackson, Mississippi, United States
• Cooper Hospital/University Medical Center — Camden, New Jersey, United States
• Cancer Center of Albany Medical Center — Albany, New York, United States
• State University of New York Health Science Center at Brooklyn — Brooklyn, New York, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• Schneider Children's Hospital at North Shore — Manhasset, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Duke Comprehensive Cancer Center — Durham, North Carolina, United States
• Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
• Barrett Cancer Center, The University Hospital — Cincinnati, Ohio, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.